Literature DB >> 1966708

High prevalence of co-occurrence of anti-HCV and anti-HBc antibodies in chronic hepatitis patients from southern Italy.

G B Gaeta1, M Rapicetta, C Sardaro, P Chionne, A Costantino, G Giusti.   

Abstract

The prevalence of anti-HCV and anti-HBV antibodies was investigated in a series of 77 adult patients with HBsAg negative, non autoimmune chronic liver disease. Anti-HCV were found in 68% and anti-HBc in 71% of the cases; 68% of the patients carried both antibodies. There was no difference in the proportion of anti-HBc positive cases between the anti-HCV positive or negative patients. The intense circulation of HBV infection in Southern Italy during the past decades might explain the high percentage of subjects with anti-HBc. Whether the co-occurrence of HCV and HBV infection may influence the natural history of the liver disease, remains to be established.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1966708

Source DB:  PubMed          Journal:  Ital J Gastroenterol        ISSN: 0392-0623


  2 in total

1.  A long-term glycyrrhizin injection therapy reduces hepatocellular carcinogenesis rate in patients with interferon-resistant active chronic hepatitis C: a cohort study of 1249 patients.

Authors:  Kenji Ikeda; Yasuji Arase; Masahiro Kobayashi; Satoshi Saitoh; Takashi Someya; Tetsuya Hosaka; Hitomi Sezaki; Norio Akuta; Yoshiyuki Suzuki; Fumitaka Suzuki; Hiromitsu Kumada
Journal:  Dig Dis Sci       Date:  2006-03       Impact factor: 3.199

2.  Survey of hepatitis B virus co-infection in hepatitis C virus-infected patients suffering from chronic hepatitis and hepatocellular carcinoma in Japan.

Authors:  K Koike; K Shimotouno; S Okada; H Okamoto; N Hayashi; K Ueda; S Kaneko; K Koike; O Yokosuka; T Chiba; H Marusawa; O Hino; T Utida; M Omata; T Juji; N Nojiri; K Takada; T Miyamura; T Osuga; Y Ito
Journal:  Jpn J Cancer Res       Date:  1999-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.